| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $631.00K | $776.00K | $569.00K | $1.18M | $776.00K |
| SG&A | $614.00K | $733.00K | $703.00K | $2.14M | $853.00K |
| Operating Income | -$1.25M | -$1.51M | -$1.27M | -$3.32M | -$1.63M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | – | – | – |
| Net Income | -$1.28M | -$1.52M | -$1.28M | -$3.36M | -$1.63M |
| EPS (basic) | 0.0700 | 0.0800 | 0.0700 | 0.2300 | 0.1500 |
| EPS (diluted) | 0.0700 | 0.0800 | 0.0700 | 0.2300 | 0.1500 |
| Shares (diluted) | $19.55M | $18.67M | $16.72M | $14.34M | $11.17M |